Journal article
Zackary Falls, Jonathan A Fine, G. Chopra, R. Samudrala
Frontiers in Chemistry, 2022
Frontiers in Chemistry, 2022
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Falls, Z., Fine, J. A., Chopra, G., & Samudrala, R. (2022). Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK. Frontiers in Chemistry.
Chicago/Turabian
Click to copy
Falls, Zackary, Jonathan A Fine, G. Chopra, and R. Samudrala. “Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK.” Frontiers in Chemistry (2022).
MLA
Click to copy
Falls, Zackary, et al. “Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK.” Frontiers in Chemistry, 2022.
BibTeX Click to copy
@article{zackary2022a,
title = {Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK},
year = {2022},
journal = {Frontiers in Chemistry},
author = {Falls, Zackary and Fine, Jonathan A and Chopra, G. and Samudrala, R.}
}
Abstract
The human immunodeficiency virus 1 (HIV-1) protease is an important target for treating HIV infection. Our goal was to benchmark a novel molecular docking protocol and determine its effectiveness as a therapeutic repurposing tool by predicting inhibitor potency to this target. To accomplish this, we predicted the relative binding scores of various inhibitors of the protease using CANDOCK, a hierarchical fragment-based docking protocol with a knowledge-based scoring function. We first used a set of 30 HIV-1 protease complexes as an initial benchmark to optimize the parameters for CANDOCK. We then compared the results from CANDOCK to two other popular molecular docking protocols Autodock Vina and Smina. Our results showed that CANDOCK is superior to both of these protocols in terms of correlating predicted binding scores to experimental binding affinities with a Pearson coefficient of 0.62 compared to 0.48 and 0.49 for Vina and Smina, respectively. We further leveraged the Database of Useful Decoys: Enhanced (DUD-E) HIV protease set to ascertain the effectiveness of each protocol in discriminating active versus decoy ligands for proteases. CANDOCK again displayed better efficacy over the other commonly used molecular docking protocols with area under the receiver operating characteristic curve (AUROC) of 0.94 compared to 0.71 and 0.74 for Vina and Smina. These findings support the utility of CANDOCK to help discover novel therapeutics that effectively inhibit HIV-1 and possibly other retroviral proteases.
